V1RE6 inhibitors belong to a specialized class of chemical compounds designed to interact with a specific type of protein structure, commonly referred to as V1RE6. Proteins that interact with these inhibitors are typically involved in a wide range of complex biochemical pathways within an organism. The specific nature of V1RE6 proteins means that inhibitors developed to bind to them are tailored to their unique structural features. These inhibitors work by binding to the V1RE6 protein in such a way that they effectively block the active site of the protein or alter its natural conformation. This binding process is highly selective and ensures that the inhibitor has a high affinity for the V1RE6 protein and not for other proteins with similar structures.
The design and synthesis of V1RE6 inhibitors are based on deep biochemical knowledge, involving a combination of computational modeling and empirical laboratory work. The structural biology of the V1RE6 protein determines the shape, charge distribution, and hydrophobic or hydrophilic properties of the inhibitor. Scientists often use techniques such as X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy and cryoelectron microscopy to ascertain the detailed structure of the protein, which in turn informs the inhibitor design process. Once developed, these inhibitors are tested in various assays to determine their efficacy in binding to the V1RE6 protein and their specificity in doing so. The process involves iterative rounds of optimization to improve the selectivity of the inhibitor and its interaction with the protein, often measured by parameters such as binding affinity and inhibitory potency. These chemical compounds are a testament to the precision required in modern chemical science, where manipulation of molecules on the smallest scale can lead to compounds with highly specific modes of action.
VEDI ANCHE...
Items 11 to 12 of 12 total
Schermo:
| Nome del prodotto | CAS # | Codice del prodotto | Quantità | Prezzo | CITAZIONI | Valutazione |
|---|---|---|---|---|---|---|
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
Il sorafenib è un inibitore di RAF che può anche inibire le chinasi VEGFR e PDGFR. Se V1RE6 si trova a valle di queste chinasi, sorafenib può portare a una riduzione dell'attività di V1RE6. | ||||||
Trametinib | 871700-17-3 | sc-364639 sc-364639A sc-364639B | 5 mg 10 mg 1 g | $114.00 $166.00 $947.00 | 19 | |
Trametinib è un inibitore di MEK che blocca la via MAPK/ERK, determinando una ridotta attivazione dei bersagli a valle, tra cui V1RE6, se coinvolto in questa via. | ||||||